BeOne Medicines AG (ONC) Q4 2025 Earnings Call Transcript
Source: SeekingAlpha
2026-02-26 16:07:50 ET
BeOne Medicines AG (ONC) Q4 2025 Earnings Call February 26, 2026 8:00 AM EST
Company Participants
Daniel Maller - Vice President of Investor Relations
John Oyler - Co-Founder, Executive Chairman & CEO
Aaron Rosenberg - Chief Financial Officer
Wang Lai - President and Global Head of Research & Development
Matt Shaulis
Xiaobin Wu
Amit Agarwal
Mark Lanasa - Senior VP & Chief Medical Officer for Solid Tumors
...
Read the full article on Seeking Alpha
For further details see:
BeOne Medicines AG (ONC) Q4 2025 Earnings Call Transcript
BeiGene Ltd.
NASDAQ: ONC
ONC Trading
0.54% G/L:
$300.67 Last:
70,533 Volume:
$293 Open:
ONC Latest News
February 26, 2026 06:00:00 am
BeOne Medicines Announces Fourth Quarter and Full Year 2025 Financial Results, Highlighting Global Success of BRUKINSA and Foundational Oncology Leadership
February 20, 2026 04:03:28 pm
HHLR Advisors Fully Exits Baidu as AI Push Tests Its Advertising-Funded Model
ONC Stock Data
$39,109,836,794
83,911,918
0.1%
106
N/A
Biotechnology & Life Sciences
Healthcare
CH
Basel
